Publications by authors named "Kai Temming"

Claim this Profile
R
Reduction of advanced liver fibrosis by short-term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats.
Montserrat Moreno, Teresa Gonzalo, Robbert J Kok, Pau Sancho-Bru, Marike van Beuge, Kai Temming

Hepatology· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RGD-avidin-biotin pretargeting to alpha v beta 3 integrin enhances the proapoptotic activity of TNF alpha related apoptosis inducing ligand (TRAIL).
Marc Tarrus, Almer M van der Sloot, Kai Temming, Marie Lacombe, Frank Opdam

Apoptosis· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Organ- and cell-type specific delivery of kinase inhibitors: a novel approach in the development of targeted drugs.
Kai Temming, Marjan M Fretz, Robbert J Kok

Curr Mol Pharmacol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved efficacy of alphavbeta3-targeted albumin conjugates by conjugation of a novel auristatin derivative.
Kai Temming, Damon L Meyer, Roger Zabinski, Peter D Senter, Klaas Poelstra

Mol Pharm· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local inhibition of liver fibrosis by specific delivery of a platelet-derived growth factor kinase inhibitor to hepatic stellate cells.
Teresa Gonzalo, Leonie Beljaars, Marja van de Bovenkamp, Kai Temming, Anne-Miek van Loenen

J Pharmacol Exp Ther· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delivery of the p38 MAPkinase inhibitor SB202190 to angiogenic endothelial cells: development of novel RGD-equipped and PEGylated drug-albumin conjugates using platinum(II)-based drug linker technology.
Kai Temming, Marie Lacombe, Paul van der Hoeven, Jai Prakash, Teresa Gonzalo

Bioconjug Chem· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antivascular therapies: targets beyond the vessel wall.
Kai Temming, Robbert J Kok

ChemMedChem· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of RGD-targeted albumin carriers for specific delivery of auristatin E to tumor blood vessels.
Kai Temming, Damon L Meyer, Roger Zabinski, Eli C F Dijkers, Klaas Poelstra

Bioconjug Chem· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational design of RGD-albumin conjugates for targeted delivery of the VEGF-R kinase inhibitor PTK787 to angiogenic endothelium.
Kai Temming, Marie Lacombe, Roel Q J Schaapveld, László Orfi, Gyorgy Kéri

ChemMedChem· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective targeting of pentoxifylline to hepatic stellate cells using a novel platinum-based linker technology.
Teresa Gonzalo, Eduard G Talman, Anke van de Ven, Kai Temming, Rick Greupink

J Control Release· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature.
Kai Temming, Raymond M Schiffelers, Grietje Molema, Robbert J Kok

Drug Resist Updat· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis